The FDA has cleared the Elecsys pTau181 test as an aid in early detection of amyloid pathology in the primary care setting for adults aged 55 years and older presenting with signs, symptoms or ...

Increased grip strength correlates with lower obesity-related disease risk, suggesting muscle power as a key factor in ...